化学标识

Spinosad Impurity B

未列出 · C41H65NO10

01化学标识

Lazychem IDLC-34293
CAS RN未列出
PubChem CID139597949
Molecular formulaC41H65NO10
Molecular weight732.0 g/mol
IUPAC name19-ethyl-4,14-dimethyl-15-[6-methyl-5-(methylamino)oxan-2-yl]oxy-7-(3,4,5-trimethoxy-6-methyloxan-2-yl)oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione
InChIKeyXZDDTAKXLUVBPD-UHFFFAOYSA-N

02结构与立体化学

2D structurePubChem CID 139597949
Two-dimensional chemical structure of Spinosad Impurity B
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 6 rings, includes aliphatic carbon. These statements are calculated from the published structure string.

Defined stereocentres0
Ring count6
Secondary amines1
Tertiary amines0
SMILESCCC1CCCC(C(C(=O)C2=CC3C4CC(CC4C(=CC3C2CC(=O)O1)C)OC5C(C(C(C(O5)C)OC)OC)OC)C)OC6CCC(C(O6)C)NC
InChI未列出

03Stereochemistry

The published structure contains 0 defined and 17 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres0Structure assigned
Unassigned centres17Structure unspecified
Assignment statusUnassignedExact published identity
Tetrahedral upper bound≤ 131,072Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04印度监管状态

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05名称与关联

原料药与母体药物

未列出

名称与关联

    杂质与相关化合物

      06来源